Fundraising Fox
Leapfrog Bio
Founded 2019 · 13 employees on LinkedIn · 1 known investors
Find your way into Leapfrog Bio
Sign up to see every warm intro you have to Leapfrog Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Leapfrog Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Leapfrog Bio is an oncology therapeutics company that uses its Precision PGx Platform to identify and develop targeted cancer treatments, focusing on patients with loss-of-function mutations through synthetic lethality and pharmacogenomic screening.
Founders & leadership
Leapfrog Bio was founded in 2019 by Tomas Babak.
Investors · 1
Two Bear Capitallisted by Two Bear CapitalWhitefish · $3M – $10M
How we know: Two Bear Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Leapfrog Bio do?
- Leapfrog Bio is an oncology therapeutics company that uses its Precision PGx Platform to identify and develop targeted cancer treatments, focusing on patients with loss-of-function mutations through synthetic lethality and pharmacogenomic screening.
- Who founded Leapfrog Bio?
- Leapfrog Bio was founded by Tomas Babak in 2019.
- Who are Leapfrog Bio's investors?
- Leapfrog Bio's investors include Two Bear Capital.